Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.

about

Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.

P2860

Q55379016-BABA0A92-868E-466B-8C2D-ED141E5A910E

P2860

Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.

Item

http://www.wikidata.org/entity/Q39556976

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Contrast-enhanced ultrasound ( ...... oing neoadjuvant chemotherapy.

@en

Contrast-enhanced ultrasound

@nl

type

Item

label

Contrast-enhanced ultrasound ( ...... oing neoadjuvant chemotherapy.

@en

Contrast-enhanced ultrasound

@nl

prefLabel

Contrast-enhanced ultrasound ( ...... oing neoadjuvant chemotherapy.

@en

Contrast-enhanced ultrasound

@nl

P1476

Contrast-enhanced ultrasound ( ...... oing neoadjuvant chemotherapy.

@en

P2093

Ariel Saracco

http://www.w3.org/2001/XMLSchema#string

Botond K Szabó

http://www.w3.org/2001/XMLSchema#string

Ervin Tánczos

http://www.w3.org/2001/XMLSchema#string

Jonas Bergh

http://www.w3.org/2001/XMLSchema#string

Thomas Hatschek

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of tumor angiogenesis with a second-generation US contrast medium in a rat breast tumor model.

Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.

Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review.

Blood vessel maturation: vascular development comes of age

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents.

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.

P304

394-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0284185116658322

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27461224

http://www.w3.org/2001/XMLSchema#string

Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.

about

P2860

P2860

Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698